Strides Pharma Science

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue416.26589.94486.97562.63528.71
Expenses398.27509.73477.85558.43519.89
EBITDA75.36145.8167.2165.6074.34
EBIT53.09108.1045.7644.2647.99
Profit Before Tax18.0065.209.134.193.52
Net Profit12.5462.408.001.282.54
Financial Ratios
Operating Profit Margin19.50%23.21%14.14%12.14%13.28%
Net Profit Margin3.24%12.68%1.68%0.24%1.32%
Earning Per Share (Diluted)1.396.910.890.140.28
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ